Iron Gene Polymorphisms are Associated to Disability , Severity and Early Progression in Multiple Sclerosis

Department of Biomedical Sciences & Advanced Therap i s, Hematology Unit -Center Hemostasis & Thrombosis-, University of Ferrara, Italy; Department of Neurology, Bellaria Hospital, Bologna Italy; Department of Medical Sciences and IRCAD, Eastern P iedmont University, Novara, Italy; Dipartimento di Biologia e Genetica per le Scienze Mediche, Università degli Studi di Milano, Italy; Stem Cell and Regenerative Biology (SCRB) Departme n , Harvard University, Cambridge, MA 02138; SCDU Neurologia, Ospedale Maggiore della Carità and IRCAD, Novara, Italy; Department of Physics, European School of Molecular Medicine (SEMM), University of Milan, Italy; Vascular Diseases Center, University of Ferrara, It aly.

[1]  M. Cambron,et al.  Vascular aspects of multiple sclerosis , 2011, The Lancet Neurology.

[2]  Jim Mintz,et al.  Gender and Iron Genes May Modify Associations Between Brain Iron and Memory in Healthy Aging , 2011, Neuropsychopharmacology.

[3]  D. Mendonça,et al.  HFE gene polymorphisms and severity in Portuguese patients with multiple sclerosis , 2011, European journal of neurology.

[4]  F. Salvi,et al.  Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report , 2011, BMC medicine.

[5]  J. Jankovic,et al.  Iron chelation and neuroprotection in neurodegenerative diseases , 2011, Journal of Neural Transmission.

[6]  C. Pozzilli,et al.  Serum elements and oxidative status in clinically isolated syndromes , 2011, Neurology.

[7]  G. Comi,et al.  Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis , 2011, Neurological Sciences.

[8]  A. González-Quintela,et al.  Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant , 2010, BMC Genetics.

[9]  S. J. Rensburg,et al.  The controversy of CCSVI and iron in multiple sclerosis: Is ferritin the key? , 2010 .

[10]  Wolfgang Vogel,et al.  Ferroportin disease: A systematic meta-analysis of clinical and molecular findings☆ , 2010, Journal of hepatology.

[11]  C. Férec,et al.  Iron metabolism in macrophages from HFE hemochromatosis patients. , 2010, Molecular genetics and metabolism.

[12]  M. Ferrari,et al.  The -582A>G variant of the HAMP promoter is not associated with high serum ferritin levels in normal subjects , 2010, Haematologica.

[13]  F. Salvi,et al.  Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis , 2010, BMC Medical Genetics.

[14]  P. Zamboni.  Chronic cerebrospinal venous insufficiency. , 2010, International angiology : a journal of the International Union of Angiology.

[15]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. , 2010, International angiology : a journal of the International Union of Angiology.

[16]  D. Gemmati,et al.  DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators. , 2009, Journal of vascular surgery.

[17]  T. Rouault,et al.  Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins , 2009, Metabolic Brain Disease.

[18]  M. Testi,et al.  Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major , 2009, Haematologica.

[19]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[20]  M. Baiget,et al.  Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes? , 2009, Annals of Hematology.

[21]  J. Stankiewicz,et al.  Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.

[22]  C. Guttmann,et al.  Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[23]  A. Sadovnick,et al.  Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis , 2008, Journal of Neuroimmunology.

[24]  Z. Rybak,et al.  Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. , 2008, Medical hypotheses.

[25]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[26]  P. Zamboni.  The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006 .

[27]  T. Rouault,et al.  Brain iron metabolism. , 2006, Seminars in pediatric neurology.

[28]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[29]  M. Kotze,et al.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis , 2006, Metabolic Brain Disease.

[30]  S. Tognazzo,et al.  The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. , 2006, Free radical biology & medicine.

[31]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[32]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[33]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[34]  F. Lublin.  Clinical features and diagnosis of multiple sclerosis. , 2005, Neurologic clinics.

[35]  J. Sullivan.  Is stored iron safe? , 2004, The Journal of laboratory and clinical medicine.

[36]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[37]  T. Speed,et al.  Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis , 2004, Human Genetics.

[38]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[39]  K. Pantopoulos.  Iron Metabolism and the IRE/IRP Regulatory System: An Update , 2004, Annals of the New York Academy of Sciences.

[40]  I. Biunno,et al.  Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. , 2004, Journal of Alzheimer's disease : JAD.

[41]  C. Wan,et al.  Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese , 2003, Neuroscience Letters.

[42]  Ya Ke,et al.  Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.

[43]  C. Beaumont,et al.  Iron metabolism, free radicals, and oxidative injury. , 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[44]  J. Hillert,et al.  HLA‐DR15 is associated with lower age at onset in multiple sclerosis , 2000, Annals of neurology.

[45]  E. Beutler,et al.  The effect of transferrin polymorphisms on iron metabolism. , 1999, Blood cells, molecules & diseases.

[46]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[47]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[48]  R. Poston,et al.  Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis , 1989, Journal of the Neurological Sciences.

[49]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[50]  Jim Mintz,et al.  Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. , 2010, Journal of Alzheimer's disease : JAD.

[51]  B. Lönnerdal,et al.  Hepcidin, the recently identified peptide that appears to regulate iron absorption. , 2004, The Journal of nutrition.

[52]  G. Salemi,et al.  Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity , 2005, Neurology.

[53]  P. Aisen.  Transferrin, the transferrin receptor, and the uptake of iron by cells. , 1998, Metal ions in biological systems.

[54]  C. Wong,et al.  Effects of transferrin genetic phenotypes on total iron-binding capacity. , 1986, Acta haematologica.